In vitro models of cancer stem cells and clinical applications

Sara S. Franco, Karolina Szczesna, Maria S. Iliou, Mohammed Al-Qahtani, Ali Mobasheri, Julianna Kobolák, A. Dinnyés

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that still none of the current non-surgical treatments can cure cancer effectively. The reason could be due to the subpopulation called "cancer stem cells" (CSCs), being defined as those cells within a tumour that have properties of stem cells: self-renewal and the ability for differentiation into multiple cell types that occur in tumours. The phenomenon of CSCs is based on their resistance to many of the current cancer therapies, which results in tumour relapse. Although further investigation regarding CSCs is still needed, there is already evidence that these cells may play an important role in the prognosis of cancer, progression and therapeutic strategy. Therefore, long-term patient survival may depend on the elimination of CSCs. Consequently, isolation of pure CSC populations or reprogramming of cancer cells into CSCs, from cancer cell lines or primary tumours, would be a useful tool to gain an in-depth knowledge about heterogeneity and plasticity of CSC phenotypes and therefore carcinogenesis. Herein, we will discuss current CSC models, methods used to characterize CSCs, candidate markers, characteristic signalling pathways and clinical applications of CSCs. Some examples of CSC-specific treatments that are currently in early clinical phases will also be presented in this review.

Original languageEnglish
Article number738
JournalBMC Cancer
Volume16
DOIs
Publication statusPublished - 2016

Fingerprint

Neoplastic Stem Cells
Neoplasms
In Vitro Techniques
Therapeutics
Critical Pathways
Carcinogenesis
Stem Cells

Keywords

  • Cancer
  • Cancer stem cells
  • Cancer therapy
  • In vitro models

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Franco, S. S., Szczesna, K., Iliou, M. S., Al-Qahtani, M., Mobasheri, A., Kobolák, J., & Dinnyés, A. (2016). In vitro models of cancer stem cells and clinical applications. BMC Cancer, 16, [738]. https://doi.org/10.1186/s12885-016-2774-3

In vitro models of cancer stem cells and clinical applications. / Franco, Sara S.; Szczesna, Karolina; Iliou, Maria S.; Al-Qahtani, Mohammed; Mobasheri, Ali; Kobolák, Julianna; Dinnyés, A.

In: BMC Cancer, Vol. 16, 738, 2016.

Research output: Contribution to journalReview article

Franco, SS, Szczesna, K, Iliou, MS, Al-Qahtani, M, Mobasheri, A, Kobolák, J & Dinnyés, A 2016, 'In vitro models of cancer stem cells and clinical applications', BMC Cancer, vol. 16, 738. https://doi.org/10.1186/s12885-016-2774-3
Franco SS, Szczesna K, Iliou MS, Al-Qahtani M, Mobasheri A, Kobolák J et al. In vitro models of cancer stem cells and clinical applications. BMC Cancer. 2016;16. 738. https://doi.org/10.1186/s12885-016-2774-3
Franco, Sara S. ; Szczesna, Karolina ; Iliou, Maria S. ; Al-Qahtani, Mohammed ; Mobasheri, Ali ; Kobolák, Julianna ; Dinnyés, A. / In vitro models of cancer stem cells and clinical applications. In: BMC Cancer. 2016 ; Vol. 16.
@article{f17bdcfd0ade41269841cbe4f78e7edc,
title = "In vitro models of cancer stem cells and clinical applications",
abstract = "Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that still none of the current non-surgical treatments can cure cancer effectively. The reason could be due to the subpopulation called {"}cancer stem cells{"} (CSCs), being defined as those cells within a tumour that have properties of stem cells: self-renewal and the ability for differentiation into multiple cell types that occur in tumours. The phenomenon of CSCs is based on their resistance to many of the current cancer therapies, which results in tumour relapse. Although further investigation regarding CSCs is still needed, there is already evidence that these cells may play an important role in the prognosis of cancer, progression and therapeutic strategy. Therefore, long-term patient survival may depend on the elimination of CSCs. Consequently, isolation of pure CSC populations or reprogramming of cancer cells into CSCs, from cancer cell lines or primary tumours, would be a useful tool to gain an in-depth knowledge about heterogeneity and plasticity of CSC phenotypes and therefore carcinogenesis. Herein, we will discuss current CSC models, methods used to characterize CSCs, candidate markers, characteristic signalling pathways and clinical applications of CSCs. Some examples of CSC-specific treatments that are currently in early clinical phases will also be presented in this review.",
keywords = "Cancer, Cancer stem cells, Cancer therapy, In vitro models",
author = "Franco, {Sara S.} and Karolina Szczesna and Iliou, {Maria S.} and Mohammed Al-Qahtani and Ali Mobasheri and Julianna Kobol{\'a}k and A. Dinny{\'e}s",
year = "2016",
doi = "10.1186/s12885-016-2774-3",
language = "English",
volume = "16",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - In vitro models of cancer stem cells and clinical applications

AU - Franco, Sara S.

AU - Szczesna, Karolina

AU - Iliou, Maria S.

AU - Al-Qahtani, Mohammed

AU - Mobasheri, Ali

AU - Kobolák, Julianna

AU - Dinnyés, A.

PY - 2016

Y1 - 2016

N2 - Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that still none of the current non-surgical treatments can cure cancer effectively. The reason could be due to the subpopulation called "cancer stem cells" (CSCs), being defined as those cells within a tumour that have properties of stem cells: self-renewal and the ability for differentiation into multiple cell types that occur in tumours. The phenomenon of CSCs is based on their resistance to many of the current cancer therapies, which results in tumour relapse. Although further investigation regarding CSCs is still needed, there is already evidence that these cells may play an important role in the prognosis of cancer, progression and therapeutic strategy. Therefore, long-term patient survival may depend on the elimination of CSCs. Consequently, isolation of pure CSC populations or reprogramming of cancer cells into CSCs, from cancer cell lines or primary tumours, would be a useful tool to gain an in-depth knowledge about heterogeneity and plasticity of CSC phenotypes and therefore carcinogenesis. Herein, we will discuss current CSC models, methods used to characterize CSCs, candidate markers, characteristic signalling pathways and clinical applications of CSCs. Some examples of CSC-specific treatments that are currently in early clinical phases will also be presented in this review.

AB - Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that still none of the current non-surgical treatments can cure cancer effectively. The reason could be due to the subpopulation called "cancer stem cells" (CSCs), being defined as those cells within a tumour that have properties of stem cells: self-renewal and the ability for differentiation into multiple cell types that occur in tumours. The phenomenon of CSCs is based on their resistance to many of the current cancer therapies, which results in tumour relapse. Although further investigation regarding CSCs is still needed, there is already evidence that these cells may play an important role in the prognosis of cancer, progression and therapeutic strategy. Therefore, long-term patient survival may depend on the elimination of CSCs. Consequently, isolation of pure CSC populations or reprogramming of cancer cells into CSCs, from cancer cell lines or primary tumours, would be a useful tool to gain an in-depth knowledge about heterogeneity and plasticity of CSC phenotypes and therefore carcinogenesis. Herein, we will discuss current CSC models, methods used to characterize CSCs, candidate markers, characteristic signalling pathways and clinical applications of CSCs. Some examples of CSC-specific treatments that are currently in early clinical phases will also be presented in this review.

KW - Cancer

KW - Cancer stem cells

KW - Cancer therapy

KW - In vitro models

UR - http://www.scopus.com/inward/record.url?scp=84991670825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991670825&partnerID=8YFLogxK

U2 - 10.1186/s12885-016-2774-3

DO - 10.1186/s12885-016-2774-3

M3 - Review article

C2 - 27766946

AN - SCOPUS:84991670825

VL - 16

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 738

ER -